0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Article |  June 01, 2002 FREE
Comparison of 2 Iron Doses in Infants Receiving Recombinant Human Erythropoietin Therapy
Shahid Nazir, MD; Ricardo L. Peverini, MD; Douglas D. Deming, MD; et al.
Arch Pediatr Adolesc Med. 2002;156(6):540-544. doi:10.1001/archpedi.156.6.540.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Editorial  |  May 11, 2011
Evaluation of Agents to Reduce Infarct Size:  It Can Be Quite REVEALing
Deepak L. Bhatt, MD, MPH
JAMA
Original Contribution  |  May 11, 2011
Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction:  REVEAL: A Randomized Controlled Trial
Samer S. Najjar, MD; Sunil V. Rao, MD; Chiara Melloni, MD, MHS; et al.
JAMA Internal Medicine
Original Investigation  |  April 23, 2007
Nononcologic Use of Human Recombinant Erythropoietin Therapy in Hospitalized Patients
Michael A. Fischer, MD, MS; Charles A. Morris, MD, MPH; Wolfgang C. Winkelmayer, MD, ScD; et al.
JAMA Internal Medicine
Editor's Correspondence  |  September 25, 2006
Erythropoietin Resistance During Androgen Deficiency—Reply
Jerry L. Spivak, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems